Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: During the three months ended August 31, 2012 and 2011...
<And when it is PR'd by the company itself I'll gladly eat my words, not extrapolated from a quarterly report that says "may" enter into recurring licensing agreements.>
Are you claiming companies can put whatever language they want into financial reports because it is all meaningless? In your view PTSC is disclosing meaningless information?
Opty
Share
New Message
Please login to post a reply